← Leaderboards
Mi Youn Lim
Chemokine Pharmaceutical, Inc.
$1,325,156
Attributed
$1,325,156
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $638.1K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$1,325,156 · 4
By mechanism
R43$1,325,156 · 4
Top collaborators
No co-investigators on record.
Most similar at Chemokine Pharmaceutical, Inc.
Same institution · by research overlap
- Krishna Kumar$387,982
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogBaseBinding (Molecular Function)BiologicalBone Marrow TransplantationCancer PatientCd4 AntigensCellsChemistry, OrganicClassClinical ResearchClinical TrialsComplicationComputer-Aided DesignComputersComputer SimulationComputer StudiesDrug Design /Synthesis /ProductionFunctional GroupFutureGraft-Vs-Host DiseaseHistocompatibility Antigens Class IiImmune ResponseAllogeneic Bone Marrow Transplantation
Grant awards (4)
New Theraputics for Graft-Versus-Host Disease$387,982
R43 · FY2007 · AI · contact PI
DEVELOPMENT OF CD8-MHC CLASS I INHIBITORS$319,074
R43 · FY2006 · AI · contact PI
STRUCTURE-BASED DISCOVERY OF CD4-MHC CLASS II INHIBITORS$319,074
R43 · FY2006 · AI · contact PI
STRUCTURE-BASED DISCOVERY OF HIV-1 ENTRY INHIBITORS$299,026
R43 · FY2005 · AI